logo
Select company
Select metric
4.14Current Ratio
VS
Market
79
Sector
59
Industry
44
History
6
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 196.87M4.14$ 47.55M
3/31/2025$ 237.18M5.65$ 42M
12/31/2024$ 276.13M6.01$ 45.95M
9/30/2024$ 295.1M9$ 32.79M
6/30/2024$ 278.97M8.15$ 34.22M
3/31/2024$ 196.76M7.47$ 26.34M
12/31/2023$ 169.19M5.42$ 31.21M
9/30/2023$ 182.12M7.06$ 25.79M
6/30/2023$ 81.33M3.04$ 26.77M
3/31/2023$ 95.97M3.8$ 25.23M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) Current Ratio stands at 7.34.
  • Over the past 5 years, UROGEN PHARMA LTD's average Current Ratio has been 6.23.
  • The median Current Ratio for UROGEN PHARMA LTD during this period was 6.16
  • UROGEN PHARMA LTD reached its highest Current Ratio over the past 5 years at 9.
  • The lowest Current Ratio recorded by UROGEN PHARMA LTD in the same timeframe 3.04

UROGEN PHARMA LTD's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
NRIX : NURIX THERAPEUTICS INC 5.35SNDX : SYNDAX PHARMACEUTICALS INC 4.71GYRE : GYRE THERAPEUTICS INC 5.4CRMD : CORMEDIX INC 7.82NAGE : NIAGEN BIOSCIENCE INC 3.88ZYME : ZYMEWORKS INC 7.69PHAT : PHATHOM PHARMACEUTICALS INC 2.38TBPH : THERAVANCE BIOPHARMA INC 6.7WVE : WAVE LIFE SCIENCES LTD 2.56KURA : KURA ONCOLOGY INC 6.16

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for UROGEN PHARMA LTD is calculated as follows: AssetsC [ $ 129.34M ] / LiabilitesC [ $ 17.62M ]
(=) Current Ratio [ 7.34 ]

URGN - Current Ratio, Last 5 years

3.04

Minimum

Jun 30, 2023

9

Maximum

Sep 30, 2024

6.23

Average

6.16

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44